¼ÓÈëVIP ÉÏ´«¿¼²©×ÊÁÏ ÄúµÄÁ÷Á¿ Ôö¼ÓÁ÷Á¿ ¿¼²©±¨°à ÿÈÕÇ©µ½
   
Ö÷Ìâ : Ò»¾Å¾Å¾ÅÄ격ʿÉúÈëѧ¿¼ÊÔÊÔÌâ(רҵ»ù´¡: ÃâÒßѧ)
¼¶±ð: ×ܰæÖ÷
ÏÔʾÓû§ÐÅÏ¢ 
Â¥Ö÷  ·¢±íÓÚ: 2007-01-25   

Ò»¾Å¾Å¾ÅÄ격ʿÉúÈëѧ¿¼ÊÔÊÔÌâ(רҵ»ù´¡: ÃâÒßѧ)

Ò»¾Å¾Å°ËÄ격ʿÑо¿ÉúÈëѧ¿¼ÊÔÊÔÌâ heZ)+}U~  
+`f gn9p  
£¨ÃâÒßѧרҵºÍרҵ»ù´¡£© G%ycAm  
/@FB;`'  
Ò».Ãû´Ê½âÊÍ£¨Ã¿Ìâ3·Ö£¬¹²45·Ö£© =YA%= d_  
m'k` p5[=h  
1.Co-stimulators (or co-stimulating molecules) C Cq<y  
SfJ/(q  
2.NK-kB $$ _ uQf  
/dOQ4VA\  
3.Immunoglobulin superfamily 0x^$q? \A  
9][Mw[k>  
4.antigen-presenting cell (APC) AG}' W  
Xki/5roCQ|  
5.death domain EUuMSDp  
m_r Re\  
6.CCR and CXCR 8GlH)J+kq  
4Hzbb#  
7.Lectin (or mitogen) SVq7qc9K?  
NlcWnSv  
8.Clusters of differentiation, CD) G#@<bg3  
7KM!\"PM  
9.B7 family /-|xxy  
g X(QRQ  
10.Cytotoxic T lymphocyte, CTL) 3J,/bgL5  
:cynZab  
11.IL-15 and IL-15 receptor (IL-15R) K4R jGSaF  
HKxrBQr78  
12.MHC restriction ~{NDtB)  
`HJwwKd  
13.Affinity-chromatography =)I{KT:y  
<kM%z{p  
14.Cyctosprin A, CsA Q@j:b]Y9  
cM"I3  
15.Antibody-dependent cell-mediated cytotoxicity, ADCC) Fwqv 1+  
%FRkvqV*  
¶þ.ÎÊ´ðÌ⣨ÿÌâ10·Ö£¬¹²30·Ö£© QMsnfG  
JH5])i0  
1.ºÎΪTh1ºÍ Th2ÑÇȺ£¿ÈçºÎ¼ì²â£¿ÔÚÁÙ´²ÉÏÓкÎÒâÒ壿 aOuon0  
\ lKQ'_  
2.ÊÔÊöÃâÒßÇòµ°°×£¨Ig£©µÄ½á¹¹Ó빦ÄܵĹØÏµ¡£ s1FBz)yCY=  
axl?t|~I  
3.ÊԱȽÏTϸ°ûÊÜÌ壨TCR/CD3£©ÓëBϸ°ûÊÜÌ壨BCR£©µÄ×é³É¡¢½á¹¹¼°Æäʶ±ð ¿¹Ô­µÄÌØµã¡£ 0jS/U|0  
 y1saE  
Èý.Ñ¡ÔñÎÊ´ðÌ⣨¸÷רҵ¿¼ÉúÖ»´ðÒ»µÀ±¾×¨ÒµÊÔÌ⣬25·Ö£© f_\-y&)+*  
RAxz+1JT  
ÃâÒßѧרҵ£º SM<kE<q#  
i_@RWka<  
1.ÊÔÊöB7/CD28, CTLA-4£¬CD40/CD40L£¬LFA-1/ICAM-1£¬CD2/LFA-3µÄ½á¹¹¡¢·Ö²¼ÒÔ¼°Ï໥×÷Óúó½éµ¼µÄÖ÷ÒªÉúÎïѧ¹¦ÄÜ¡£ ,ym;2hJ  
I6fpXPP).  
Ïû»¯ÄÚ¿Æ£º _7;^od=C  
w~&]gyf  
2.Ö×Áö¿¹Ô­·ÖΪÄļ¸Àࣿ»úÌ忹Ö×ÁöÃâÒßÖ÷ÒªÓÐÄÄЩÒòËØ£¨»úÖÆ£©£¿¼òÊöÌá¸ß¿¹Ö×ÁöÃâÒßÑо¿µÄÂԲߡ£ ^m=%Ctu#  
9|`@czw  
ѪҺ²¡Ñ§×¨Òµ£º 5HN<*u%z  
Y<+4>Eh  
3.ºÎΪ°×Ѫ²¡µÄÃâÒßѧ·ÖÐÍ£¿ºÎÎªÒÆÖ²ÎËÞÖ÷·´Ó¦£*****VHR£©£¿GVHR·¢ÉúµÄÖ÷ÒªÔ­Òò£¨Ìõ¼þ£©ÊÇʲô£¿
ÆÀ¼ÛÒ»ÏÂÄãä¯ÀÀ´ËÌû×ӵĸÐÊÜ

¾«²Ê

¸Ð¶¯

¸ãЦ

¿ªÐÄ

·ßÅ­

ÎÞÁÄ

¹àË®

  
ÃèÊö
¿ìËٻظ´

ÑéÖ¤ÎÊÌâ:
2+6=? ÕýÈ·´ð°¸:8
°´"Ctrl+Enter"Ö±½ÓÌá½»